CN112205617A - Diet suitable for people with diabetes and needing to control blood sugar - Google Patents
Diet suitable for people with diabetes and needing to control blood sugar Download PDFInfo
- Publication number
- CN112205617A CN112205617A CN201910624582.3A CN201910624582A CN112205617A CN 112205617 A CN112205617 A CN 112205617A CN 201910624582 A CN201910624582 A CN 201910624582A CN 112205617 A CN112205617 A CN 112205617A
- Authority
- CN
- China
- Prior art keywords
- powder
- diet
- diabetes
- cinnamon
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000005911 diet Nutrition 0.000 title claims abstract description 56
- 230000037213 diet Effects 0.000 title claims abstract description 56
- 239000008280 blood Substances 0.000 title claims abstract description 44
- 210000004369 blood Anatomy 0.000 title claims abstract description 44
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 38
- 239000000843 powder Substances 0.000 claims abstract description 136
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 49
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 49
- 240000000249 Morus alba Species 0.000 claims abstract description 43
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 43
- 235000016709 nutrition Nutrition 0.000 claims abstract description 18
- 230000035764 nutrition Effects 0.000 claims abstract description 18
- 239000002131 composite material Substances 0.000 claims abstract description 17
- 239000003623 enhancer Substances 0.000 claims abstract description 17
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- 244000302512 Momordica charantia Species 0.000 claims abstract description 15
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 15
- 235000021329 brown rice Nutrition 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 235000013373 food additive Nutrition 0.000 claims abstract description 13
- 239000002778 food additive Substances 0.000 claims abstract description 13
- 235000015097 nutrients Nutrition 0.000 claims abstract description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 239000000905 isomalt Substances 0.000 claims abstract description 5
- 235000010439 isomalt Nutrition 0.000 claims abstract description 5
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- 238000002156 mixing Methods 0.000 claims description 43
- 238000001914 filtration Methods 0.000 claims description 26
- 238000001035 drying Methods 0.000 claims description 23
- 239000002994 raw material Substances 0.000 claims description 20
- 238000004806 packaging method and process Methods 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 claims description 16
- 244000285963 Kluyveromyces fragilis Species 0.000 claims description 16
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- 229910052725 zinc Inorganic materials 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 12
- 229910052804 chromium Inorganic materials 0.000 claims description 12
- 239000011651 chromium Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 229910052711 selenium Inorganic materials 0.000 claims description 9
- 239000011669 selenium Substances 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 8
- 238000007781 pre-processing Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 7
- 238000009461 vacuum packaging Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 5
- 239000000428 dust Substances 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- 230000000291 postprandial effect Effects 0.000 abstract description 7
- 230000001684 chronic effect Effects 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 5
- 201000001421 hyperglycemia Diseases 0.000 abstract description 5
- 210000000496 pancreas Anatomy 0.000 abstract description 5
- 230000002641 glycemic effect Effects 0.000 abstract description 4
- 208000018914 glucose metabolism disease Diseases 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 23
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 208000013016 Hypoglycemia Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 2
- 201000008980 hyperinsulinism Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012778 molding material Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- QHMQAWNNHVPBQU-UHFFFAOYSA-N 3-(2-hydroxy-3-methylphenyl)-1-phenylprop-2-en-1-one Chemical compound CC1=CC=CC(C=CC(=O)C=2C=CC=CC=2)=C1O QHMQAWNNHVPBQU-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 235000009815 Momordica Nutrition 0.000 description 1
- 241000218984 Momordica Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compounds Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000004104 gestational diabetes Diseases 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a diet suitable for people with diabetes and needing to control blood sugar, which is prepared from the following materials in parts by weight: 1.0-10.0g of brown rice powder; 1.0-10.0g of skim milk powder; isomalt 1.0-10.0 g; 1.0-10.0g of mulberry leaf powder; 1.0-10.0g of balsam pear powder; 1.0-10.0g of kudzu root powder; 1.0-10.0g of cinnamon powder; 0.1-5.0g of composite nutrition enhancer; 0.1-5.0g of nutrient yeast powder and 0.1-5.0g of food additive. The invention provides a diet suitable for people with diabetes and needing to control blood sugar, and the technical scheme designs a brand-new diet aiming at the physique of a chronic diabetes patient, so that the diet is convenient to eat, safe and reliable, and does not produce secondary damage to other visceral organs. On the other hand, the functional components capable of effectively relieving postprandial blood sugar and reducing the glycemic index are added. The product of the invention is beneficial to relieving glucose metabolism disorder of diabetics, improving tolerance during treatment, reducing pancreas and islet burden, reducing incidence of complications of hyperglycemia patients, improving life quality of patients and the like.
Description
Technical Field
The invention relates to a diet, in particular to a diet suitable for people with diabetes and people needing to control blood sugar.
Background
At present, diabetes mellitus becomes a common disease and a frequently encountered disease in many countries all over the world, the mortality rate of the diabetes mellitus is third after tumors and cardiovascular diseases, and the number of diabetes mellitus patients in China is the first global. Diabetes is a common endocrine metabolic disease, which is mainly characterized by persistent hyperglycemia, positive urine glucose and low glucose tolerance, typical symptoms are 'three more one less' symptoms such as polydipsia, polyphagia, polyuria, weight loss and the like, and the basic pathological features are absolute or relative insufficiency of insulin secretion or reduction of sensitivity of peripheral tissues to insulin, so that a systemic disease mainly comprising glucose metabolism disorder including fat and protein metabolism disorder is caused. Currently, diabetes is classified as: type 1 diabetes, type 2 diabetes, non-specific diabetes and gestational diabetes, wherein type 2 diabetes accounts for more than forty percent of the whole diabetes, type 2 diabetes is a lifelong disease, complications can involve multiple organs, the disability and fatality rate is high, the physical and mental health of a patient is seriously affected, and heavy burden is brought to individuals, families and society. Research shows that the prevalence rate of chronic complications of diabetic patients in China is as high as 65.1%, wherein patients with hypertension, cardiovascular and cerebrovascular diseases, eye and kidney diseases are about 1/3%, and patients with neuropathy are about 61.9%. The morbidity of the cardiovascular complications is 17.1 percent, and the cardiovascular complications become chronic complications with the highest disability rate and mortality rate and the greatest harm of diabetes in China. The hazards of type 2 diabetes itself and its chronic complications, coupled with high direct and indirect costs, have made type 2 diabetes a major public health problem worldwide, and the prevention and control of diabetes and its chronic complications have become a serious challenge for countries throughout the world.
The defects of the modern medicine are as follows:
1. side effects of sulfonylureas: hypoglycemia, weight increment, easy skin allergy, pruritus, erythema, urticaria, pimple, headache, dizziness, somnolence, blurred vision, tremor and physical balance disorder, and the drug effect of people taking the drug for more than one year is reduced; the main side effect of the alpha-glucosidase inhibitor is gastrointestinal reaction, specifically abdominal distension, gastrectasia, upper abdominal burning pain, diarrhea or constipation, if the dosage is continuously increased after long-term use, the body can generate drug resistance;
2. side effects of metformin: the long-term use of the medicine can easily cause lactic acidosis and poor digestive tract of patients with hyperglycemia, can further cause damage to liver and kidney, and can seriously cause ketoacidosis;
3. side effects of long-term insulin administration: it may cause weight gain in people, especially abdominal obesity, which is common in type 2 diabetics, and may also cause hypoglycemia, because of overdose of injected insulin and lack of proper time for eating, and hypoglycemia and even coma in people with liver and kidney insufficiency.
The medicament has large side effect, is produced by nutrient intervention through food, is convenient to use, is safe and reliable, does not produce secondary damage to other visceral organs, and has good tolerance. Through nutritional intervention, the glycemic index of starch food is reduced, the activity of alpha-amylase is inhibited, the digestion and absorption of carbohydrate are delayed, the postprandial blood sugar is reduced, the sharp rise of the postprandial blood sugar can be effectively relieved, the load of pancreas and pancreatic islet is reduced, and the incidence rate of infection and complications of hyperglycemia patients is reduced.
Disclosure of Invention
The invention aims to provide a diet suitable for people with diabetes and people who need to control blood sugar, so as to solve the problems in the background technology.
A diet suitable for people with diabetes and needing to control blood sugar is composed of the following materials in parts by weight: 1.0-10.0g of brown rice powder; 1.0-10.0g of skim milk powder; isomalt 1.0-10.0 g; 1.0-10.0g of mulberry leaf powder; 1.0-10.0g of balsam pear powder; 1.0-10.0g of kudzu root powder; 1.0-10.0g of cinnamon powder; 0.1-5.0g of composite nutrition enhancer; 0.1-5.0g of nutrient yeast powder and 0.1-5.0g of food additive.
A production process of a diet suitable for people with diabetes and needing to control blood sugar comprises the following steps:
s1, preprocessing: selecting high-quality mulberry leaves for cleaning, removing dust and impurities on the surface, and then drying and dehydrating the cleaned mulberry leaves;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-volume ratio of the mulberry leaves to the ethanol is 1:8, the concentration of the ethanol is eighty percent), extracting the mulberry leaves for three times, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the filtered solutions for three times;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.01-1.03, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving folium Mori powder with 80 mesh sieve, and mixing the sieved materials;
s4, packaging: and carrying out vacuum packaging on the mulberry leaf powder subjected to pretreatment, extraction, filtration and drying mixing.
The production process of the cinnamon powder in the diet comprises the following steps:
s1, preprocessing: selecting high-quality cinnamon, cleaning to remove impurities on the surface of the cinnamon, and then drying and dehydrating the cleaned cinnamon;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-ethanol volume ratio of cinnamon is 1:8, the concentration of ethanol is eighty percent), extracting cinnamon twice, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the solutions after two times of filtering;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.03-1.05, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving with 80 mesh sieve, and mixing well;
s4, packaging: and (3) carrying out vacuum packaging on the cinnamon powder which is subjected to pretreatment, extraction, filtration and drying mixing.
The preparation of each forming material of the diet comprises the following steps:
SA, batching: the raw materials of brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder, food additives and the like are accurately weighed according to the specified quantity of a production material list for later use;
SB, mixing: mixing various raw materials prepared according to a proportion by using a mixer at a rotating speed of 15r/min, wherein the mixing sequence is that the number of the raw materials is more than or equal to that specified by a material-taking list, each mixing time is not less than 15min until all the raw materials are added, and the mixing time is 60min, and filling the mixed powder into a sterilized container for later use;
step SC, subpackaging: packaging with an automatic particle packaging machine until the net content meets the quantitative package commodity measurement supervision and management method;
step SD and packaging: and filling the semi-finished bags obtained by subpackage into paper boxes and big boxes according to the quantity requirement of product packages, sealing the boxes, and handling warehousing procedures after the semi-finished bags are qualified.
In the diet, brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder and a food additive are selected from real-time high-quality raw materials.
The proportion of brown rice powder, skim milk powder, isomaltitol and nutritional yeast powder in the diet is 3: 1: 2: 0.5.
the ratio of mulberry leaf powder to cinnamon powder in the diet is 1: 1-5: 1.
The composite nutrition enhancer in the diet is added with calcium, zinc and iron (calcium is less than or equal to 600mg, zinc is less than or equal to 12mg and iron is less than or equal to 10 mg).
The nutrient yeast powder added into the diet is added with chromium and selenium (20-25 ug of chromium and less than or equal to 20ug of selenium).
Compared with the prior art, the invention has the beneficial effects that:
1. the kudzu root and the mulberry leaf are added, the kudzu root is common food which is also approved by the Ministry of health and can be used as both medicine and food, the puerarin as an active ingredient can repair and protect islet cells, inhibit the secretion of glucagon and promote the secretion of insulin, improve an insulin resistance system, enhance the sensitivity of an insulin receptor, promote the combination with the insulin receptor and improve the biological effect of the insulin cells, so that the stable and quick blood sugar reduction is realized, the blood vessels of a diabetic patient can be activated, the elasticity of smooth muscles is increased, the blood vessel resistance is reduced, the blood flow speed is increased, and the deposition of substances in the blood vessels is reduced; the mulberry leaves are rich in flavone compounds such as quercetin, isoquercetin, rutin and the like, and both the mulberry leaf alkaloid and the mulberry leaf polysaccharide can improve the insulin resistance state, inhibit the activity of alpha-glucosidase and directly inhibit glucose absorption, remarkably control the increase of fasting blood glucose value, reduce the blood glucose value and the area under the blood glucose curve and increase the sensitivity of insulin;
2. according to the invention, cinnamon and bitter gourd are added, the cinnamon is pungent, sweet and hot in taste, has the effects of warming and invigorating kidney yang, warming middle-jiao and expelling cold, and diffusing and guiding blood vessels, and can inhibit the decomposition of sucrase, maltase and alpha-amylase in a human body on starch or sugar, so that the absorption of the human body on sugar is blocked, the rise of blood sugar is inhibited, and diabetes is prevented. The functional component of the methyl hydroxy chalcone polymer can not only imitate insulin and accelerate glucose metabolism in cells by more than 20 times, but also inhibit the activity of alpha-amylase, delay the digestion and absorption of carbohydrates and reduce the glycemic index of starch foods; fructus Momordicae Charantiae is plant of Momordica of Cucurbitaceae, and its fruit has effects of clearing summerheat, clearing heat, improving eyesight, and removing toxic substance, and can be used for treating damp-heat dysentery, hematochezia, furuncle and toxic swelling, and toothache due to pathogenic wind-fire;
3. according to the invention, the nutritional yeast powder is added, the nutritional yeast powder is one of chromium nutrition supplement sources specified by the national food and drug administration, and the nutritional yeast powder is converted into organic chromium through biotransformation, so that the organic chromium is beneficial to reducing toxic and side effects in vivo, improving the absorption and utilization rate in vivo, improving the intestinal microecology, proliferating intestinal beneficial bacteria, reducing the blood sugar level and the insulin level, and improving the sugar tolerance.
Drawings
FIG. 1 is a flow chart of the processing of mulberry leaf powder and cinnamon powder in a diet suitable for people with diabetes and needing to control blood sugar, and a production process thereof;
fig. 2 is a process flow chart of the diet suitable for people with diabetes and needing to control blood sugar and the production process thereof.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Referring to fig. 1-2, the present invention provides the following technical solutions: a diet suitable for people with diabetes and needing to control blood sugar is composed of the following materials in parts by weight: 3.0g of brown rice powder; 1.0g of skim milk powder; isomalt 2.0 g; 3.5 parts of mulberry leaf powder; 4.0g of balsam pear powder; 3.0g of kudzu root powder; 3.0g of cinnamon powder; 0.2g of composite nutrition enhancer; 0.5g of nutrient yeast powder and 0.1g of food additive.
A production process of a diet suitable for people with diabetes and needing to control blood sugar comprises the following steps:
s1, preprocessing: selecting high-quality mulberry leaves for cleaning, removing dust and impurities on the surface, and then drying and dehydrating the cleaned mulberry leaves;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-volume ratio of the mulberry leaves to the ethanol is 1:8, the concentration of the ethanol is eighty percent), extracting the mulberry leaves for three times, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the filtered solutions for three times;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.01-1.03, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving folium Mori powder with 80 mesh sieve, and mixing the sieved materials;
s4, packaging: and carrying out vacuum packaging on the mulberry leaf powder subjected to pretreatment, extraction, filtration and drying mixing.
Preferably, the production process of the cinnamon powder in the diet comprises the following steps:
s1, preprocessing: selecting high-quality cinnamon, cleaning to remove impurities on the surface of the cinnamon, and then drying and dehydrating the cleaned cinnamon;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-ethanol volume ratio of cinnamon is 1:8, the concentration of ethanol is eighty percent), extracting cinnamon twice, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the solutions after two times of filtering;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.03-1.05, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving with 80 mesh sieve, and mixing well;
s4, packaging: and (3) carrying out vacuum packaging on the cinnamon powder which is subjected to pretreatment, extraction, filtration and drying mixing.
Preferably, the preparation of each molding material of the diet comprises the following steps:
SA, batching: the raw materials of brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder, food additives and the like are accurately weighed according to the specified quantity of a production material list for later use;
SB, mixing: mixing various raw materials prepared according to a proportion by using a mixer at a rotating speed of 15r/min, wherein the mixing sequence is that the number of the raw materials is more than or equal to that specified by a material-taking list, each mixing time is not less than 15min until all the raw materials are added, and the mixing time is 60min, and filling the mixed powder into a sterilized container for later use;
step SC, subpackaging: packaging with an automatic particle packaging machine until the net content meets the quantitative package commodity measurement supervision and management method;
step SD and packaging: and filling the semi-finished bags obtained by subpackage into paper boxes and big boxes according to the quantity requirement of product packages, sealing the boxes, and handling warehousing procedures after the semi-finished bags are qualified.
Preferably, the coarse rice powder, the skim milk powder, the isomaltitol, the mulberry leaf powder, the balsam pear powder, the kudzu root powder, the cinnamon powder, the composite nutrition enhancer, the nutritional yeast powder and the food additive in the diet are all selected from real-time high-quality raw materials.
Preferably, the proportion of the brown rice powder, the skim milk powder, the isomaltitol and the nutritional yeast powder in the diet is 3: 1: 2: 0.5.
preferably, the ratio of the mulberry leaf powder to the cinnamon powder in the diet is 1: 1-5: 1.
Preferably, the composite nutrition enhancer in the diet is added with calcium, zinc and iron (calcium is less than or equal to 600mg, zinc is less than or equal to 12mg and iron is less than or equal to 10 mg), and the calcium is beneficial to preventing osteoporosis; zinc participates in the synthesis and degradation of insulin, and when zinc is deficient, the loss of zinc in pancreas and beta cells is increased, the synthesis of insulin is reduced, hyperinsulinemia can be caused, and insulin resistance is generated; iron can form heme, enrich blood, improve immunity, and improve physical quality.
Preferably, chromium and selenium (20-25 ug of chromium and less than or equal to 20ug of selenium) are added into the nutrient yeast powder added into the diet, and the chromium is beneficial to improving the sugar tolerance; selenium is an important component of glutathione peroxidase, and can scavenge oxygen free radicals and prevent complications.
Example 2
Referring to fig. 1-2, the present invention provides the following technical solutions: a diet suitable for people with diabetes and needing to control blood sugar is composed of the following materials in parts by weight: 6.0g of brown rice powder; 2.0g of skim milk powder; isomalt 4.0 g; 3.5g of mulberry leaves; 4.0g of balsam pear; 3.0g of kudzu root; 3.0g of cinnamon; 0.4g of composite nutrition enhancer; 1.0g of nutrient yeast powder and 0.2g of food additive.
Preferably, the production process of the diet suitable for people with diabetes and people who need to control blood sugar comprises the following steps:
s1, preprocessing: selecting high-quality mulberry leaves for cleaning, removing dust and impurities on the surface, and then drying and dehydrating the cleaned mulberry leaves;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-volume ratio of the mulberry leaves to the ethanol is 1:8, the concentration of the ethanol is eighty percent), extracting the mulberry leaves for three times, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the filtered solutions for three times;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.01-1.03, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving with 80 mesh sieve, and mixing.
Preferably, the production process of the cinnamon powder in the diet comprises the following steps:
s1, preprocessing: selecting high-quality cinnamon, cleaning to remove impurities on the surface of the cinnamon, and then drying and dehydrating the cleaned cinnamon;
s2, extraction and filtration: weighing 8 times of ethanol (the weight-to-ethanol volume ratio of cinnamon is 1:8, the concentration of ethanol is eighty percent), extracting cinnamon twice, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the solutions after two times of filtering;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.03-1.05, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving with 80 mesh sieve, and mixing well;
s4, packaging: and (3) carrying out vacuum packaging on the cinnamon powder which is subjected to pretreatment, extraction, filtration and drying mixing.
Preferably, the preparation of each molding material of the diet comprises the following steps:
SA, batching: the raw materials of brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder, food additives and the like are accurately weighed according to the specified quantity of a production material list for later use;
SB, mixing: mixing various raw materials prepared according to a proportion by using a mixer at a rotating speed of 15r/min, wherein the mixing sequence is that the number of the raw materials is more than or equal to that specified by a material-taking list, each mixing time is not less than 15min until all the raw materials are added, and the mixing time is 60min, and filling the mixed powder into a sterilized container for later use;
step SC, subpackaging: packaging with an automatic particle packaging machine until the net content meets the quantitative package commodity measurement supervision and management method;
step SD and packaging: and filling the semi-finished bags obtained by subpackage into paper boxes and big boxes according to the quantity requirement of product packages, sealing the boxes, and handling warehousing procedures after the semi-finished bags are qualified.
Preferably, the coarse rice powder, the skim milk powder, the isomaltitol, the mulberry leaf powder, the balsam pear powder, the kudzu root powder, the cinnamon powder, the composite nutrition enhancer, the nutritional yeast powder and the food additive in the diet are all selected from real-time high-quality raw materials.
Preferably, the proportion of the brown rice powder, the skim milk powder, the isomaltitol and the nutritional yeast powder in the diet is 3: 1: 2: 0.5.
preferably, the ratio of the mulberry leaf powder to the cinnamon powder in the diet is 1: 1-5: 1.
Preferably, the composite nutrition enhancer in the diet is added with calcium, zinc and iron (calcium is less than or equal to 600mg, zinc is less than or equal to 12mg and iron is less than or equal to 10 mg), and the calcium is beneficial to preventing osteoporosis; zinc participates in the synthesis and degradation of insulin, and when zinc is deficient, the loss of zinc in pancreas and beta cells is increased, the synthesis of insulin is reduced, hyperinsulinemia can be caused, and insulin resistance is generated; iron can form heme, enrich blood, improve immunity, and improve physical quality.
Preferably, chromium and selenium (20-25 ug of chromium and less than or equal to 20ug of selenium) are added into the nutrient yeast powder added into the diet, and the chromium is beneficial to improving the sugar tolerance; selenium is an important component of glutathione peroxidase, and can scavenge oxygen free radicals and prevent complications.
The following are examples of the present invention:
experimental data
And (3) analyzing experimental data:
front fasting blood glucose-rear fasting blood glucose
Percent of empty stomach decreased blood sugar = () -Yi (2) -xi (2) -X (100)%
Fasting plasma glucose before test
2 hours post prandial blood glucose-2 hours post prandial blood glucose
After 2 hours, the percentage of blood sugar decrease = - — -
2 hours post-prandial blood glucose before the test
| Group A (taking meal) | Group B (taking placebo) | |
| Fasting blood glucose decrease (%) | 10.5±0.6 | 2.4±0.1 |
| Blood glucose decrease after 2 hours after meal (%) | 10.1±0.5 | 1.2±0.1 |
| Glycated hemoglobin (%) | 13.5±0.3 | 16.0±0.5 |
After taking the medicine twice a day for two months, the diabetes is obviously improved, the thirst is improved, the spirit is good, the sleep is good, and the defecation is good.
According to the invention, by adding the kudzu root powder, the mulberry leaf powder, the cinnamon powder, the balsam pear powder and the nutritional yeast powder, a brand new diet is designed for the physique of a chronic diabetic patient, on one hand, the use is convenient, the use is safe and reliable, and no secondary damage is generated to other visceral organs. On the other hand, the functional components capable of effectively relieving postprandial blood sugar and reducing the glycemic index are added. The product of the invention is beneficial to relieving glucose metabolism disorder of diabetics, improving tolerance during treatment, reducing pancreas and islet burden, reducing incidence of complications of hyperglycemia patients, improving life quality of patients and the like.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (9)
1. A diet suitable for people with diabetes and needing to control blood sugar is characterized in that: the material composition comprises the following materials in percentage by weight: 1.0-10.0g of brown rice powder; 1.0-10.0g of skim milk powder; isomalt 1.0-10.0 g; 1.0-10.0g of mulberry leaf powder; 1.0-10.0g of balsam pear powder; 1.0-10.0g of kudzu root powder; 1.0-10.0g of cinnamon powder; 0.1-5.0g of composite nutrition enhancer; 0.1-5.0g of nutrient yeast powder and 0.1-5.0g of food additive.
2. A production process of a diet suitable for people with diabetes and needing to control blood sugar is characterized in that: the production process of the mulberry leaf powder in the diet comprises the following steps:
s1, preprocessing: selecting high-quality mulberry leaves for cleaning, removing dust and impurities on the surface, and then drying and dehydrating the cleaned mulberry leaves;
s2, extraction and filtration: weighing 8 times of ethanol, wherein the volume ratio of the weight of the mulberry leaves to the ethanol is 1:8, the concentration of the ethanol is eighty percent, extracting the mulberry leaves for three times, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the filtered solutions for three times;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.01-1.03, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving folium Mori powder with 80 mesh sieve, and mixing the sieved materials;
s4, packaging: and carrying out vacuum packaging on the mulberry leaf powder subjected to pretreatment, extraction, filtration and drying mixing.
3. The process for producing a diet suitable for people with diabetes and who need to control blood glucose as claimed in claim 2, wherein: the production process of the cinnamon powder in the diet comprises the following steps:
s1, preprocessing: selecting high-quality cinnamon, cleaning to remove impurities on the surface of the cinnamon, and then drying and dehydrating the cleaned cinnamon;
s2, extraction and filtration: weighing 8 times of ethanol, wherein the volume ratio of the weight of the cinnamon to the ethanol is 1:8, the concentration of the ethanol is eighty percent, extracting the cinnamon twice, extracting for two hours each time, controlling the temperature to be 80 +/-5 ℃, then filtering again, and merging the solutions filtered twice;
s3, drying and mixing: concentrating at 60 + -5 deg.C, vacuum degree of 0.040-0.080MPa, and relative density of 1.03-1.05, spray drying at inlet air temperature of 140-190 deg.C and outlet air temperature of 75-85 deg.C, sieving with 80 mesh sieve, and mixing well;
s4, packaging: and (3) carrying out vacuum packaging on the cinnamon powder which is subjected to pretreatment, extraction, filtration and drying mixing.
4. The process for producing a diet suitable for people with diabetes and who need to control blood glucose as claimed in claim 2, wherein: the preparation method of the diet comprises the following steps:
SA, batching: the raw materials of brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder, food additives and the like are accurately weighed according to the specified quantity of a production material list for later use;
SB, mixing: mixing various raw materials prepared according to a proportion by using a mixer at a rotating speed of 15r/min, wherein the mixing sequence is that the number of the raw materials is more than or equal to that specified by a material-taking list, each mixing time is not less than 15min until all the raw materials are added, and the mixing time is 60min, and filling the mixed powder into a sterilized container for later use;
step SC, subpackaging: packaging with an automatic particle packaging machine;
step SD and packaging: and filling the semi-finished bags obtained by subpackage into paper boxes and big boxes according to the quantity requirement of product packages, sealing the boxes, and handling warehousing procedures after the semi-finished bags are qualified.
5. The diet as claimed in claim 1, suitable for people with diabetes and who need to control blood sugar, wherein: in the diet, brown rice powder, skim milk powder, isomaltitol, mulberry leaf powder, bitter gourd powder, kudzuvine root powder, cinnamon powder, a composite nutrition enhancer, nutritional yeast powder and a food additive are selected from real-time high-quality raw materials.
6. The diet as claimed in claim 1, suitable for people with diabetes and who need to control blood sugar, wherein: the proportion of brown rice powder, skim milk powder, isomaltitol and nutritional yeast powder in the diet is 3: 1: 2: 0.5.
7. the diet as claimed in claim 1, suitable for people with diabetes and who need to control blood sugar, wherein: the ratio of mulberry leaf powder to cinnamon powder in the diet is 1: 1-5: 1.
8. The diet as claimed in claim 1, suitable for people with diabetes and who need to control blood sugar, wherein: the composite nutrition enhancer in the diet is added with less than or equal to 600mg of calcium, less than or equal to 12mg of zinc and less than or equal to 10mg of iron.
9. The diet as claimed in claim 1, suitable for people with diabetes and who need to control blood sugar, wherein: the nutrient yeast powder added in the diet is added with 20-25 ug of chromium and less than or equal to 20ug of selenium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910624582.3A CN112205617A (en) | 2019-07-11 | 2019-07-11 | Diet suitable for people with diabetes and needing to control blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910624582.3A CN112205617A (en) | 2019-07-11 | 2019-07-11 | Diet suitable for people with diabetes and needing to control blood sugar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112205617A true CN112205617A (en) | 2021-01-12 |
Family
ID=74047576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910624582.3A Pending CN112205617A (en) | 2019-07-11 | 2019-07-11 | Diet suitable for people with diabetes and needing to control blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112205617A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113854458A (en) * | 2021-09-30 | 2021-12-31 | 江苏冠尔生物科技有限公司 | Mulberry leaf solid instant beverage, intermediate and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103504315A (en) * | 2013-02-26 | 2014-01-15 | 中美御康生物科技（北京）有限公司 | Composite dietary fiber and preparation method |
| CN103610752A (en) * | 2013-11-21 | 2014-03-05 | 华侨大学 | Functional food with hypoglycemic effect and preparation method thereof |
| CN106974288A (en) * | 2017-05-09 | 2017-07-25 | 张新成 | It is adapted to nutrient powder of patients with diabetes mellitus and preparation method thereof |
| CN107468898A (en) * | 2017-09-11 | 2017-12-15 | 邹立影 | A kind of diabetic's special food and preparation method thereof |
| CN108095085A (en) * | 2017-12-25 | 2018-06-01 | 陕西三正医用营养有限公司 | A kind of specific full nutrition special medicine purposes formula food of diabetes and preparation method thereof |
| CN108523138A (en) * | 2017-03-02 | 2018-09-14 | 劲膳美食品股份有限公司 | A kind of hypoglycemic meal replacement powder |
| CN109170470A (en) * | 2018-10-10 | 2019-01-11 | 吉林健盛科技有限公司 | A kind of solid beverage and preparation method thereof for treating diabetes |
-
2019
- 2019-07-11 CN CN201910624582.3A patent/CN112205617A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103504315A (en) * | 2013-02-26 | 2014-01-15 | 中美御康生物科技（北京）有限公司 | Composite dietary fiber and preparation method |
| CN103610752A (en) * | 2013-11-21 | 2014-03-05 | 华侨大学 | Functional food with hypoglycemic effect and preparation method thereof |
| CN108523138A (en) * | 2017-03-02 | 2018-09-14 | 劲膳美食品股份有限公司 | A kind of hypoglycemic meal replacement powder |
| CN106974288A (en) * | 2017-05-09 | 2017-07-25 | 张新成 | It is adapted to nutrient powder of patients with diabetes mellitus and preparation method thereof |
| CN107468898A (en) * | 2017-09-11 | 2017-12-15 | 邹立影 | A kind of diabetic's special food and preparation method thereof |
| CN108095085A (en) * | 2017-12-25 | 2018-06-01 | 陕西三正医用营养有限公司 | A kind of specific full nutrition special medicine purposes formula food of diabetes and preparation method thereof |
| CN109170470A (en) * | 2018-10-10 | 2019-01-11 | 吉林健盛科技有限公司 | A kind of solid beverage and preparation method thereof for treating diabetes |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113854458A (en) * | 2021-09-30 | 2021-12-31 | 江苏冠尔生物科技有限公司 | Mulberry leaf solid instant beverage, intermediate and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106616187A (en) | Solid beverage capable of assisting to lower hypertension, hyperglycemia and hyperlipidemia | |
| CN103478738A (en) | Composite with weight-reducing, body-shaping and weight-controlling functions | |
| CN109221898A (en) | A kind of grain dust and its preparation method and application containing xylo-oligosaccharide | |
| CN107752024A (en) | A kind of nutritional meal replacing food for improving the metabolic disturbance diseases such as three height and obesity | |
| CN109315574A (en) | A kind of mulberry leaf balsam pear pressed candy | |
| CN108420065A (en) | A kind of antihypelipidemic product rich in bitter gourd polypeptide | |
| CN107198767A (en) | It is a kind of to be used to prevent three high red yeast rice balsam pear complex peptides pieces | |
| CN102113652A (en) | Special dietary extruded rice applicable to patients suffering from 'five-high' metabolic syndrome and preparation method thereof | |
| CN111165806A (en) | Multifunctional selenium-rich nutritional food and preparation method thereof | |
| CN114711374A (en) | Composite nutrient powder of ferment fibre and its preparation method | |
| CN110710660A (en) | Blood sugar lowering composition and dietary supplement containing bitter gourd powder | |
| CN117044945B (en) | Food composition with function of controlling blood sugar rise, and preparation method and application thereof | |
| CN104082820A (en) | Hypoglycemic soluble granules containing alfalfa | |
| CN112205617A (en) | Diet suitable for people with diabetes and needing to control blood sugar | |
| CN105410930A (en) | Health-care product with weight-losing and body-slimming and nutrition-balancing functions and preparation method thereof | |
| EP3574912B1 (en) | Composition for treating diabetic disease | |
| CN111281902A (en) | Application of lithocarpus litseifolius or active extract thereof | |
| CN106974274A (en) | A kind of three high drop tonic agent | |
| CN113598372A (en) | Composition for intervening hyperglycemia and preparation method thereof | |
| UA112174C2 (en) | METHOD OF GETTING HERBAL EXTRACT | |
| KR101391647B1 (en) | Anti obesity composition | |
| CN102198174B (en) | Traditional Chinese medicine formulated preparation for nourishing kidney, removing heat from liver, reducing sugar and regulating fat, and preparation method thereof | |
| CN105963567B (en) | The drug and preparation method for treating diabetes | |
| CN1826972A (en) | Health-caring product capable of reducing blood sugar | |
| CN109700015A (en) | Postprandial blood sugar suitable for III crowd of visible peristalsis visible intestinal peristalsis adjusts the dietary composition with prevention |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210112 |